{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T02:16:33Z","timestamp":1783131393164,"version":"3.54.6"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,2,11]],"date-time":"2020-02-11T00:00:00Z","timestamp":1581379200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,2,11]],"date-time":"2020-02-11T00:00:00Z","timestamp":1581379200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100005156","name":"Alexander von Humboldt-Stiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005156","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1007\/s00213-020-05477-0","type":"journal-article","created":{"date-parts":[[2020,2,11]],"date-time":"2020-02-11T03:02:40Z","timestamp":1581390160000},"page":"1521-1532","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":72,"title":["Perceived outcomes of psychedelic microdosing as self-managed therapies for mental and substance use disorders"],"prefix":"10.1007","volume":"237","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5942-0550","authenticated-orcid":false,"given":"Toby","family":"Lea","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Amada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Jungaberle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrike","family":"Schecke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert","family":"Scherbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,2,11]]},"reference":[{"key":"5477_CR1","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s12954-019-0308-4","volume":"16","author":"T Anderson","year":"2019","unstructured":"Anderson T, Petranker R, Christopher A, Rosenbaum D, Weissman C, Dinh-Williams L-A, Hui K, Hapke E (2019a) Psychedelic microdosing benefits and challenges: an empirical codebook. Harm Reduct J 16:43","journal-title":"Harm Reduct J"},{"key":"5477_CR2","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1007\/s00213-018-5106-2","volume":"236","author":"T Anderson","year":"2019","unstructured":"Anderson T, Petranker R, Rosenbaum D, Weissman CR, Dinh-Williams L-A, Hui K, Hapke E, Farb NA (2019b) Microdosing psychedelics: personality, mental health, and creativity differences in microdosers. Psychopharmacology 236:731\u2013740","journal-title":"Psychopharmacology"},{"key":"5477_CR3","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/0277-9536(93)90033-Z","volume":"36","author":"A Antonovsky","year":"1993","unstructured":"Antonovsky A (1993) The structure and properties of the sense of coherence scale. Soc Sci Med 36:725\u2013733","journal-title":"Soc Sci Med"},{"key":"5477_CR4","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.drugpo.2018.11.006","volume":"66","author":"E Argento","year":"2019","unstructured":"Argento E, Tupper KW, Socias ME (2019) The tripping point: the potential role of psychedelic-assisted therapy in the response to the opioid crisis. Int J Drug Policy 66:80\u201381","journal-title":"Int J Drug Policy"},{"key":"5477_CR5","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.biopsych.2019.05.019","volume":"86","author":"AK Bershad","year":"2019","unstructured":"Bershad AK, Schepers ST, Bremmer MP, Lee R, de Wit H (2019) Acute subjective and behavioral effects of microdoses of LSD in healthy human volunteers. Biol Psychiatry 86:792\u2013800","journal-title":"Biol Psychiatry"},{"key":"5477_CR6","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1177\/0269881114565144","volume":"29","author":"MP Bogenschutz","year":"2015","unstructured":"Bogenschutz MP, Forcehimes AA, Pommy JA, Wilcox CE, Barbosa P, Strassman RJ (2015) Psilocybin-assisted treatment for alcohol dependence: a proof-of-concept study. J Psychopharmacol 29:289\u2013299","journal-title":"J Psychopharmacol"},{"key":"5477_CR7","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s00213-017-4771-x","volume":"235","author":"R Carhart-Harris","year":"2018","unstructured":"Carhart-Harris R, Bolstridge M, Day C, Rucker J, Watts R, Erritzoe D, Kaelen M, Giribaldi B, Bloomfield M, Pilling S (2018) Psilocybin with psychological support for treatment-resistant depression: six-month follow-up. Psychopharmacology 235:399\u2013408","journal-title":"Psychopharmacology"},{"key":"5477_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jad.2007.06.006","volume":"106","author":"AE Castaneda","year":"2008","unstructured":"Castaneda AE, Tuulio-Henriksson A, Marttunen M, Suvisaari J, L\u00f6nnqvist J (2008) A review on cognitive impairments in depressive and anxiety disorders with a focus on young adults. J Affect Disord 106:1\u201327","journal-title":"J Affect Disord"},{"key":"5477_CR9","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1016\/S0140-6736(17)32802-7","volume":"391","author":"A Cipriani","year":"2018","unstructured":"Cipriani A, Furukawa TA, Salanti G, Chaimani A, Atkinson LZ, Ogawa Y, Leucht S, Ruhe HG, Turner EH, Higgins JP (2018) Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. Lancet 391:1357\u20131366","journal-title":"Lancet"},{"key":"5477_CR10","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1001\/jamapsychiatry.2016.2586","volume":"74","author":"CR Conway","year":"2017","unstructured":"Conway CR, George MS, Sackeim HA (2017) Toward an evidence-based, operational definition of treatment-resistant depression: when enough is enough. JAMA Psychiat 74:9\u201310","journal-title":"JAMA Psychiat"},{"key":"5477_CR11","unstructured":"Dean J (2017) Micro-dosing: the drug habit your boss is gonna love. GQ January 4. Available via https:\/\/www.gq.com\/story\/micro-dosing-lsd"},{"key":"5477_CR12","volume-title":"The psychedelic explorer\u2019s guide: safe, therapeutic, and sacred journeys","author":"J Fadiman","year":"2011","unstructured":"Fadiman J (2011) The psychedelic explorer\u2019s guide: safe, therapeutic, and sacred journeys. Park Street Press, Rochester"},{"key":"5477_CR13","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1080\/02791072.2019.1593561","volume":"51","author":"J Fadiman","year":"2019","unstructured":"Fadiman J, Korb S (2019) Might microdosing psychedelics be safe and beneficial? An initial exploration. J Psychoactive Drugs 51:118\u2013122","journal-title":"J Psychoactive Drugs"},{"key":"5477_CR14","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1097\/NMD.0000000000000113","volume":"202","author":"P Gasser","year":"2014","unstructured":"Gasser P, Holstein D, Michel Y, Doblin R, Yazar-Klosinski B, Passie T, Brenneisen R (2014) Safety and efficacy of lysergic acid diethylamide-assisted psychotherapy for anxiety associated with life-threatening diseases. J Nerv Ment Dis 202:513\u2013520","journal-title":"J Nerv Ment Dis"},{"key":"5477_CR15","unstructured":"Glatter R (2015) LSD microdosing: the new job enhancer in Silicon Valley and beyond? Forbes November 27. Available via https:\/\/www.forbes.com\/sites\/robertglatter\/2015\/11\/27\/lsd-microdosing-the-new-job-enhancer-in-silicon-valley-and-beyond\/#1261fba7188a"},{"key":"5477_CR16","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1001\/jamapsychiatry.2015.2132","volume":"73","author":"BF Grant","year":"2016","unstructured":"Grant BF, Saha TD, Ruan WJ, Goldstein RB, Chou SP, Jung J, Zhang H, Smith SM, Pickering RP, Huang B (2016) Epidemiology of DSM-5 drug use disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions\u2013III. JAMA Psychiat 73:39\u201347","journal-title":"JAMA Psychiat"},{"key":"5477_CR17","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1177\/0269881116675513","volume":"30","author":"RR Griffiths","year":"2016","unstructured":"Griffiths RR, Johnson MW, Carducci MA, Umbricht A, Richards WA, Richards BD, Cosimano MP, Klinedinst MA (2016) Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: a randomized double-blind trial. J Psychopharmacol 30:1181\u20131197","journal-title":"J Psychopharmacol"},{"key":"5477_CR18","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1192\/bjp.bp.114.148551","volume":"206","author":"M Hoskins","year":"2015","unstructured":"Hoskins M, Pearce J, Bethell A, Dankova L, Barbui C, Tol WA, Van Ommeren M, De Jong J, Seedat S, Chen H (2015) Pharmacotherapy for post-traumatic stress disorder: systematic review and meta-analysis. Br J Psychiatry 206:93\u2013100","journal-title":"Br J Psychiatry"},{"key":"5477_CR19","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.peh.2019.01.001","volume":"6","author":"A Hupli","year":"2019","unstructured":"Hupli A, Berning M, Zhuparris A, Fadiman J (2019) Descriptive assemblage of psychedelic microdosing: netnographic study of Youtube\u2122 videos and on-going research projects. Perform Enhanc Health 6:129\u2013138","journal-title":"Perform Enhanc Health"},{"key":"5477_CR20","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1353\/pbm.2018.0049","volume":"61","author":"P Hutchinson","year":"2018","unstructured":"Hutchinson P, Moerman DE (2018) The meaning response, \u201cplacebo,\u201d and methods. Perspect Biol Med 61:361\u2013378","journal-title":"Perspect Biol Med"},{"key":"5477_CR21","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1093\/ijnp\/pyz029","volume":"22","author":"NR Hutten","year":"2019","unstructured":"Hutten NR, Mason NL, Dolder PC, Kuypers KP (2019a) Motives and side-effects of microdosing with psychedelics among users. Int J Neuropsychopharmacol 22:426\u2013434","journal-title":"Int J Neuropsychopharmacol"},{"key":"5477_CR22","doi-asserted-by":"publisher","first-page":"672","DOI":"10.3389\/fpsyt.2019.00672","volume":"10","author":"NR Hutten","year":"2019","unstructured":"Hutten NR, Mason NL, Dolder PC, Kuypers KP (2019b) Self-rated effectiveness of microdosing with psychedelics for mental and physical health problems amongst microdosers. Front Psych 10:672","journal-title":"Front Psych"},{"key":"5477_CR23","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1177\/0269881114548296","volume":"28","author":"MW Johnson","year":"2014","unstructured":"Johnson MW, Garcia-Romeu A, Cosimano MP, Griffiths RR (2014) Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction. J Psychopharmacol 28:983\u2013992","journal-title":"J Psychopharmacol"},{"key":"5477_CR24","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3109\/00952990.2016.1170135","volume":"43","author":"MW Johnson","year":"2017","unstructured":"Johnson MW, Garcia-Romeu A, Griffiths RR (2017) Long-term follow-up of psilocybin-facilitated smoking cessation. Am J Drug Alcohol Abuse 43:55\u201360","journal-title":"Am J Drug Alcohol Abuse"},{"key":"5477_CR25","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1177\/1455072517753339","volume":"35","author":"PG Johnstad","year":"2018","unstructured":"Johnstad PG (2018) Powerful substances in tiny amounts: an interview study of psychedelic microdosing. Nordic Stud Alcohol Drugs 35:39\u201351","journal-title":"Nordic Stud Alcohol Drugs"},{"key":"5477_CR26","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1080\/02791072.2015.1094590","volume":"47","author":"V Kavensk\u00e1","year":"2015","unstructured":"Kavensk\u00e1 V, Simonov\u00e1 H (2015) Ayahuasca tourism: participants in shamanic rituals and their personality styles, motivation, benefits and risks. J Psychoactive Drugs 47:351\u2013359","journal-title":"J Psychoactive Drugs"},{"key":"5477_CR27","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1124\/pr.115.010967","volume":"67","author":"ER Korpi","year":"2015","unstructured":"Korpi ER, den Hollander B, Farooq U, Vashchinkina E, Rajkumar R, Nutt DJ, Hyytiae P, Dawe GS (2015) Mechanisms of action and persistent neuroplasticity by drugs of abuse. Pharmacol Rev 67:872\u20131004","journal-title":"Pharmacol Rev"},{"key":"5477_CR28","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1177\/0269881112439253","volume":"26","author":"TS Krebs","year":"2012","unstructured":"Krebs TS, Johansen P-\u00d8 (2012) Lysergic acid diethylamide (LSD) for alcoholism: meta-analysis of randomized controlled trials. J Psychopharmacol 26:994\u20131002","journal-title":"J Psychopharmacol"},{"key":"5477_CR29","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","volume":"16","author":"K Kroenke","year":"2001","unstructured":"Kroenke K, Spitzer RL, Williams JB (2001) The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 16:606\u2013613","journal-title":"J Gen Intern Med"},{"key":"5477_CR30","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1177\/0269881119857204","volume":"33","author":"KP Kuypers","year":"2019","unstructured":"Kuypers KP, Ng L, Erritzoe D, Knudsen GM, Nichols CD, Nichols DE, Soula A, Nutt D (2019) Microdosing psychedelics: more questions than answers? An overview and suggestions for future research. J Psychopharmacol 33:1039\u20131057","journal-title":"J Psychopharmacol"},{"key":"5477_CR31","doi-asserted-by":"crossref","unstructured":"Lea T, Amada N, Jungaberle H (2019) Psychedelic microdosing: a subreddit analysis. J Psychoactive Drugs:Published online 25 November 2019. 2010.1016\/j.drugpo.2019.2011.2008","DOI":"10.1080\/02791072.2019.1683260"},{"key":"5477_CR32","first-page":"1052","volume":"33","author":"ME Liechti","year":"2019","unstructured":"Liechti ME (2019) Psychedelics: what are low doses and \u2018microdoses\u2019? Commentary on Kuypers et al. (2019). J Psychopharmacol 33:1052\u20131053","journal-title":"J Psychopharmacol"},{"key":"5477_CR33","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1556\/2054.2018.006","volume":"2","author":"NL Mason","year":"2018","unstructured":"Mason NL, Kuypers KPC (2018) Mental health of a self-selected sample of psychedelic users and self-medication practices with psychedelics. J Psychedelic Stud 2:45\u201352","journal-title":"J Psychedelic Stud"},{"key":"5477_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jad.2009.04.022","volume":"119","author":"LM McDermott","year":"2009","unstructured":"McDermott LM, Ebmeier KP (2009) A meta-analysis of depression severity and cognitive function. J Affect Disord 119:1\u20138","journal-title":"J Affect Disord"},{"key":"5477_CR35","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1111\/dar.12194","volume":"33","author":"J Milward","year":"2014","unstructured":"Milward J, Lynskey M, Strang J (2014) Solving the problem of non-attendance in substance abuse services. Drug Alcohol Rev 33:625\u2013636","journal-title":"Drug Alcohol Rev"},{"key":"5477_CR36","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.1007\/s00213-019-05249-5","volume":"236","author":"MC Mithoefer","year":"2019","unstructured":"Mithoefer MC, Feduccia AA, Jerome L, Mithoefer A, Wagner M, Walsh Z, Hamilton S, Yazar-Klosinski B, Emerson A, Doblin R (2019) MDMA-assisted psychotherapy for treatment of PTSD: study design and rationale for phase 3 trials based on pooled analysis of six phase 2 randomized controlled trials. Psychopharmacology 236:2735\u20132745","journal-title":"Psychopharmacology"},{"key":"5477_CR37","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1192\/bjb.2017.11","volume":"42","author":"J Moncrieff","year":"2018","unstructured":"Moncrieff J (2018) Against the stream: antidepressants are not antidepressants\u2013an alternative approach to drug action and implications for the use of antidepressants. BJPsych Bull 42:42\u201344","journal-title":"BJPsych Bull"},{"key":"5477_CR38","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1177\/1087054714558872","volume":"19","author":"AM Mowinckel","year":"2015","unstructured":"Mowinckel AM, Pedersen ML, Eilertsen E, Biele G (2015) A meta-analysis of decision-making and attention in adults with ADHD. J Atten Disord 19:355\u2013367","journal-title":"J Atten Disord"},{"key":"5477_CR39","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1124\/pr.115.011478","volume":"68","author":"DE Nichols","year":"2016","unstructured":"Nichols DE (2016) Psychedelics. Pharmacol Rev 68:264\u2013355","journal-title":"Pharmacol Rev"},{"key":"5477_CR40","doi-asserted-by":"publisher","unstructured":"Noorani T (2019) Making psychedelics into medicines: the politics and paradoxes of medicalization. J Psychedelic Stud. https:\/\/doi.org\/10.1556\/2054.2019.1018","DOI":"10.1556\/2054.2019.1018"},{"key":"5477_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/1179069518800508","volume":"12","author":"DE Olson","year":"2018","unstructured":"Olson DE (2018) Psychoplastogens: a promising class of plasticity-promoting neurotherapeutics. J Exp Neurosci 12:1\u20134","journal-title":"J Exp Neurosci"},{"key":"5477_CR42","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1017\/S0033291718001356","volume":"49","author":"F Palhano-Fontes","year":"2019","unstructured":"Palhano-Fontes F, Barreto D, Onias H, Andrade KC, Novaes MM, Pessoa JA, Mota-Rolim SA, Os\u00f3rio FL, Sanches R, dos Santos RG (2019) Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial. Psychol Med 49:655\u2013663","journal-title":"Psychol Med"},{"key":"5477_CR43","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1192\/bjp.180.2.104","volume":"180","author":"S Pampallona","year":"2002","unstructured":"Pampallona S, Bollini P, Tibaldi G, Kupelnick B, Munizza C (2002) Patient adherence in the treatment of depression. Br J Psychiatry 180:104\u2013109","journal-title":"Br J Psychiatry"},{"key":"5477_CR44","volume-title":"The science of microdosing psychedelics","author":"T Passie","year":"2019","unstructured":"Passie T (2019) The science of microdosing psychedelics. Psychedelic Press, London"},{"key":"5477_CR45","doi-asserted-by":"publisher","first-page":"e0211023","DOI":"10.1371\/journal.pone.0211023","volume":"14","author":"V Politi","year":"2019","unstructured":"Politi V, Stevenson RJ (2019) A systematic study of microdosing psychedelics. PLoS One 14:e0211023","journal-title":"PLoS One"},{"key":"5477_CR46","doi-asserted-by":"publisher","first-page":"3401","DOI":"10.1007\/s00213-018-5049-7","volume":"235","author":"L Prochazkova","year":"2018","unstructured":"Prochazkova L, Lippelt DP, Colzato LS, Kuchar M, Sjoerds Z, Hommel B (2018) Exploring the effect of microdosing psychedelics on creativity in an open-label natural setting. Psychopharmacology 235:3401\u20133413","journal-title":"Psychopharmacology"},{"key":"5477_CR47","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.addbeh.2018.08.021","volume":"88","author":"J Read","year":"2019","unstructured":"Read J, Gee A, Diggle J, Butler H (2019) Staying on, and coming off, antidepressants: the experiences of 752 UK adults. Addict Behav 88:82\u201385","journal-title":"Addict Behav"},{"key":"5477_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pnpbp.2017.09.012","volume":"81","author":"S Reiche","year":"2018","unstructured":"Reiche S, Hermle L, Gutwinski S, Jungaberle H, Gasser P, Maji\u0107 T (2018) Serotonergic hallucinogens in the treatment of anxiety and depression in patients suffering from a life-threatening disease: a systematic review. Prog Neuro-Psychopharmacol Biol Psychiatry 81:1\u201310","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"5477_CR49","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1177\/0269881116675512","volume":"30","author":"S Ross","year":"2016","unstructured":"Ross S, Bossis A, Guss J, Agin-Liebes G, Malone T, Cohen B, Mennenga SE, Belser A, Kalliontzi K, Babb J (2016) Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial. J Psychopharmacol 30:1165\u20131180","journal-title":"J Psychopharmacol"},{"key":"5477_CR50","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.drugpo.2015.11.005","volume":"28","author":"A Roxburgh","year":"2016","unstructured":"Roxburgh A, Lea T, de Wit J, Degenhardt L (2016) Sexual identity and prevalence of alcohol and other drug use among Australians in the general population. Int J Drug Policy 28:76\u201382","journal-title":"Int J Drug Policy"},{"key":"5477_CR51","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1007\/s00213-017-4713-7","volume":"235","author":"B Sessa","year":"2018","unstructured":"Sessa B (2018) The 21st century psychedelic renaissance: heroic steps forward on the back of an elephant. Psychopharmacology 235:551\u2013560","journal-title":"Psychopharmacology"},{"key":"5477_CR52","doi-asserted-by":"publisher","first-page":"e230109","DOI":"10.1136\/bcr-2019-230109","volume":"12","author":"B Sessa","year":"2019","unstructured":"Sessa B, Sakal C, O\u2019Brien S, Nutt D (2019) First study of safety and tolerability of 3, 4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy in patients with alcohol use disorder: preliminary data on the first four participants. BMJ Case Rep 12:e230109","journal-title":"BMJ Case Rep"},{"key":"5477_CR53","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1001\/archinte.166.10.1092","volume":"166","author":"RL Spitzer","year":"2006","unstructured":"Spitzer RL, Kroenke K, Williams JB, L\u00f6we B (2006) A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med 166:1092\u20131097","journal-title":"Arch Intern Med"},{"key":"5477_CR54","volume-title":"A really good day: how microdosing made a mega difference in my mood, my marriage, and my life","author":"A Waldman","year":"2017","unstructured":"Waldman A (2017) A really good day: how microdosing made a mega difference in my mood, my marriage, and my life. Alfred A, Knopf"},{"key":"5477_CR55","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.drugpo.2019.04.013","volume":"70","author":"M Webb","year":"2019","unstructured":"Webb M, Copes H, Hendricks PS (2019) Narrative identity, rationality, and microdosing classic psychedelics. Int J Drug Policy 70:33\u201339","journal-title":"Int J Drug Policy"},{"key":"5477_CR56","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1016\/S0140-6736(13)61611-6","volume":"382","author":"HA Whiteford","year":"2013","unstructured":"Whiteford HA, Degenhardt L, Rehm J, Baxter AJ, Ferrari AJ, Erskine HE, Charlson FJ, Norman RE, Flaxman AD, Johns N (2013) Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010. Lancet 382:1575\u20131586","journal-title":"Lancet"},{"key":"5477_CR57","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1071\/AH13142","volume":"38","author":"HA Whiteford","year":"2014","unstructured":"Whiteford HA, Buckingham WJ, Harris MG, Burgess PM, Pirkis JE, Barendregt JJ, Hall WD (2014) Estimating treatment rates for mental disorders in Australia. Aust Health Rev 38:80\u201385","journal-title":"Aust Health Rev"},{"key":"5477_CR58","unstructured":"Williams A (2017) How LSD saved one woman\u2019s marriage. New York Times January 7. Available via https:\/\/www.nytimes.com\/2017\/01\/07\/style\/microdosing-lsd-ayelet-waldman-michael-chabon-marriage.html"},{"key":"5477_CR59","unstructured":"World Health Organization (2017) Depression and other common mental disorders: global health estimates. WHO, Geneva"},{"key":"5477_CR60","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1007\/s00213-018-5119-x","volume":"236","author":"S Yanakieva","year":"2019","unstructured":"Yanakieva S, Polychroni N, Family N, Williams LT, Luke DP, Terhune DB (2019) The effects of microdose LSD on time perception: a randomised, double-blind, placebo-controlled trial. Psychopharmacology 236:1159\u20131170","journal-title":"Psychopharmacology"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-020-05477-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-020-05477-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-020-05477-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,10]],"date-time":"2021-02-10T07:00:01Z","timestamp":1612940401000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-020-05477-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,11]]},"references-count":60,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["5477"],"URL":"https:\/\/doi.org\/10.1007\/s00213-020-05477-0","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,11]]},"assertion":[{"value":"14 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study received ethical approval from the University of Duisburg-Essen, Germany (Reference: 18-8215-BO).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}